Adaptimmune Therapeutics PLC (ADAP)
0.7963
+0.02
(+2.50%)
USD |
NASDAQ |
Nov 08, 16:00
0.7963
0.00 (0.00%)
After-Hours: 16:02
Adaptimmune Therapeutics Research and Development Expense (% of Annual Revenues)
Research and Development Expense (% of Annual Revenues) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (% of Annual Revenues) Data
| Date | Value |
|---|---|
| December 31, 2023 | -- |
| December 31, 2022 | -- |
| December 31, 2021 | -- |
| December 31, 2020 | -- |
| December 31, 2019 | -- |
| December 31, 2018 | -- |
| Date | Value |
|---|---|
| December 31, 2017 | -- |
| December 31, 2016 | -- |
| December 31, 2015 | -- |
| June 30, 2015 | -- |
| June 30, 2014 | -- |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.